Poseida Therapeutics Funding & Investors
Poseida Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. The Company utilizes proprietary gene engineering platform technologies to create next generation cell and gene therapeutics.
poseida.comTotal Amount Raised: $435,449,984
Poseida Therapeutics Funding Rounds
Post Ipo Equity
$25,000,000
Post Ipo Equity Investors
Astellas PharmaPost Ipo Equity
$25,000,000
Post Ipo Equity Investors
Astellas PharmaPost Ipo Equity
$70,000,000
Post Ipo Equity
$70,000,000
Series D
$110,000,000
Series D Investors
Schonfeld Strategic AdvisorsAdage Capital ManagementFidelity Management and Research CompanySeries D
$110,000,000
Series D Investors
Schonfeld Strategic AdvisorsAdage Capital ManagementFidelity Management and Research CompanySeries C
$142,000,000
Series C Investors
NovartisRapha Capital ManagementMalinVivo CapitalPerceptive AdvisorsLongitude CapitalPentwater Capital ManagementBoxer CapitalAisling CapitalSeries C
$142,000,000
Series C Investors
NovartisRapha Capital ManagementMalinVivo CapitalPerceptive AdvisorsLongitude CapitalPentwater Capital ManagementBoxer CapitalAisling CapitalGrant
$3,990,000
Grant Investors
California Institute for Regenerative MedicineSeries B
$30,500,000
Series B Investors
MalinVivo CapitalTavistock GroupLongitude CapitalGrant
$3,990,000
Grant Investors
California Institute for Regenerative MedicineSeries B
$30,500,000
Series B Investors
MalinVivo CapitalTavistock GroupLongitude CapitalGrant
$19,800,000
Grant Investors
California Institute for Regenerative MedicineGrant
$19,800,000
Grant Investors
California Institute for Regenerative MedicineSeries A
$11,160,002
Series A Investors
MalinEric OstertagSeries A
$23,000,000
Series A Investors
MalinEric OstertagSeries A
$11,160,002
Series A Investors
MalinEric OstertagSeries A
$23,000,000
Series A Investors
MalinEric Ostertag
Funding info provided by Diffbot.